The weekly litigation news digest is live. Subscribe now

IP Verse

Engineered Natural Killer Cells And Uses Thereof

Patent No. EP3895712 (titled "Engineered Natural Killer Cells And Uses Thereof") was filed by ONK Therapeutics on Dec 11, 2017. The application was issued on Jun 22, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AMMELBURGMar 21, 2023FISH & RICHARDSON PC

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3895712

ONK THERAPEUTICS
Application Number
EP21160170A
Filing Date
Dec 11, 2017
Status
Granted And Under Opposition
May 20, 2022
Publication Date
Jun 22, 2022
External Links
Slate, EP3895712B1, Google Patents